Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 27th June 2018
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New Equine Virus test launched
NEV is often misdiagnosed or hidden by other diseases that cause similar symptoms.
Test to prevent misdiagnosis of often fatal disease

The first commercial diagnostic test for New Equine Virus (NEV) has been launched.

First discovered in 2013, NEV is often misdiagnosed or hidden by other diseases that cause similar symptoms, such as anaemia and neurological problems.

It is most often confused with the Swamp Fever virus (EIAV) and Equine Herpesvirus (EHV).

Now, thanks to research by equine biotech firm Equigerminal, vets, laboratories and horse owners will be able to identify this often fatal disease and administer the appropriate treatment.

The test requires a vet to take a blood sample from the horse and send it to the Equigerminal lab. The blood is then analysed and the results are returned to the owner or vet.

When the results are returned, the horse can be given treatment and the spread of the disease can be prevented. Currently, treatment is aimed towards improving the general wellbeing of the horse, monitoring its health and boosting the immune system.

NEV was discovered by Portuguese scientist and veterinary surgeon Isabel Fidalgo Carvalho while completing her PhD in Equine Sciences at the Universities of Oporto and Pittsburgh.

“During my time at University and at Equigerminal, I noticed unusual anaemia and severe neurological signs in horses, which in my PhD I wrongly hypothesized to be attributed to Swamp Fever,” she said. “I then realised, through the samples, that this virus was actually closer to equine HIV – New Equine Virus, or NEV”.

After her discovery, Carvalho launched Equigerminal with fellow scientist Alexandre Vieira Pires.

“We have spent the last five years developing a diagnostic test and a potential cure for NEV.” explains Pires.“We now need to raise awareness of the problem and help vets to diagnose this disease correctly.”

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.